Showing results (151-160 of 3,348) with videos related to

Sort By:
Pageof 335
Pharmacoeconomics|February 28, 2004
The cost effectiveness of tacrolimus versus microemulsified cyclosporin: a 10-year model of renal transplantation outcomesMichelle E Orme, Wieslaw A Jurewicz, Nagappan Kumar, et al.
Pharmacoeconomics|August 11, 2006
Pharmacoeconomic analyses of azathioprine, methotrexate and prospective pharmacogenetic testing for the management of inflammatory bowel diseaseVirginia L Priest, Evan J Begg, Sharon J Gardiner, et al.
Pharmacoeconomics|August 11, 2006
Costs of inflammatory bowel disease in GermanyRenee Stark, Hans-Helmut König, Reiner Leidl
Pharmacoeconomics|June 28, 2006
Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in SpainArran T Shearer, Adrian Bagust, F Javier Ampudia-Blasco, et al.
Pharmacoeconomics|September 28, 2006
Disability and quality of life in post-traumatic stress disorder: impact of drug treatmentSoraya Seedat, Christine Lochner, Bavanisha Vythilingum, et al.
Pharmacoeconomics|September 28, 2006
Hospitalisation costs of cystic fibrosisJonas Schreyögg, Helge Hollmeyer, Miriam Bluemel, et al.
Pharmacoeconomics|November 5, 2004
Clinical and economic impact of epoetins in cancer careMonia Marchetti, Giovanni Barosi
Pharmacoeconomics|February 8, 2005
Q-TWiST analysis of cyclophosphamide, epirubicin, fluorouracil versus cyclophosphamide, methotrexate, fluorouracil treatment for premenopausal women with node-positive breast cancerDavide Radice, Alberto Redaelli
Pharmacoeconomics|February 8, 2005
A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care settingAnthony H Harris, Elena Gospodarevskaya, Alison J Ritter
Pharmacoeconomics|May 7, 2005
The burden of coronary, cerebrovascular and peripheral arterial diseaseAmeet Bakhai
Pageof 335